Application of quantitative PCR to the diagnosis and monitoring of Pseudomonas aeruginosa colonization in 5–18-year-old cystic fibrosis patients

References

1. Burns J. L., Gibson R. L., McNamara S., Yim D., Emerson J., Rosenfeld M., Hiatt P., McCoy K., Castile R. other authors 2001; Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J Infect Dis 183:444–452 [CrossRef]
   [Google Scholar]
2. Deschaght P., De Baere T., Van Simaey L., Van Daele S., De Baets F., De Vos D., Pirnay J.-P., Vaneechoutte M. 2009; Comparison of the sensitivity of culture, PCR and quantitative real-time PCR for the detection of Pseudomonas aeruginosa in sputum of cystic fibrosis patients. BMC Microbiol 9:244 [CrossRef]
   [Google Scholar]
3. De Vos D., Lim A. Jr, Pirnay J.-P., Struelens M., Vandenvelde C., Duinslaeger L., Vanderkelen A., Cornelis P. 1997; Direct detection and identification of Pseudomonas aeruginosa in clinical samples such as skin biopsy specimens and expectorations by multiplex PCR based on two outer membrane lipoprotein genes,oprI and oprL . J Clin Microbiol 35:1295–1299
   [Google Scholar]
4. De Vos D., De Chial M., Cochez C., Jansen S., Tümmler B., Meyer J.-M., Cornelis P. 2001; Study of pyoverdine type and production by Pseudomonas aeruginosa isolated from cystic fibrosis patients: prevalence of type II pyoverdine isolates and accumulation of pyoverdine-negative mutations. Arch Microbiol 175:384–388 [CrossRef]
   [Google Scholar]
5. Frederiksen B., Koch C., Høiby N. 1997; Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis. Pediatr Pulmonol 23:330–335 [CrossRef]
   [Google Scholar]
6. Frederiksen B., Koch C., Høiby N. 1999; Changing epidemiology of Pseudomonas aeruginosa infection in Danish cystic fibrosis patients (1974–1995. Pediatr Pulmonol 28:159–166 [CrossRef]
   [Google Scholar]
7. Høiby N., Frederiksen B., Pressler T. 2005; Eradication of early Pseudomonas aeruginosa infection. J Cyst Fibros 4:49–54
   [Google Scholar]
8. Karpati F., Jonasson J. 1996; Polymerase chain reaction for the detection of Pseudomonas aeruginosa , Stenotrophomonas maltophilia and Burkholderia cepacia in sputum of patients with cystic fibrosis. Mol Cell Probes 10:397–403 [CrossRef]
   [Google Scholar]
9. Pirnay J.-P., De Vos D., Duinslaeger L., Reper P., Vandenvelde C., Cornelis P., Vanderkelen A. 2000; Quantitation of Pseudomonas aeruginosa in wound biopsy samples: from bacterial culture to rapid 'real-time' polymerase chain reaction. Crit Care 4:255–261 [CrossRef]
   [Google Scholar]
10. Rosenfeld M., Emerson J., Williams-Warren J., Pepe M., Smith A., Montgomery A. B., Ramsey B. W. 2001a; Defining a pulmonary exacerbation in cystic fibrosis. J Pediatr 139:359–365 [CrossRef]
    [Google Scholar]
11. Rosenfeld M., Gibson R. L., McNamara S., Emerson J., Burns J. L., Castile R., Hiatt P., McCoy K., Wilson C. B. other authors 2001b; Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis. Pediatr Pulmonol 32:356–366 [CrossRef]
    [Google Scholar]
12. Rosenfeld M., Ramsey B. W., Gibson R. L. 2003; Pseudomonas acquisition in young patients with cystic fibrosis: pathophysiology, diagnosis, and management. Curr Opin Pulm Med 9:492–497 [CrossRef]
    [Google Scholar]
13. van Belkum A., Renders N. H. M., Smith S., Overbeek S. E., Verbrugh H. A. 2000; Comparison of conventional and molecular methods for the detection of bacterial pathogens in sputum samples from cystic fibrosis patients. FEMS Immunol Med Microbiol 27:51–57 [CrossRef]
    [Google Scholar]
14. Xu J., Moore J. E., Murphy P. G., Millar B. C., Elborn J. S. 2004; Early detection of Pseudomonas aeruginosa : comparison of conventional versus molecular (PCR) detection directly from adult patients with cystic fibrosis (CF). Ann Clin Microbiol Antimicrob 3:21 [CrossRef]
    [Google Scholar]